Cargando…
High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer
PURPOSE: The enhancer of zeste homologue 2 (EZH2) is a catalytic subunit of the polycomb repressive complex 2, a highly conserved histone methyltransferase. EZH2 overexpression has been implicated in various malignancies, including breast cancer, where is associated with poor outcomes. This study ai...
Autores principales: | Jang, Si-Hyong, Lee, Jong Eun, Oh, Mee-Hye, Lee, Ji-Hye, Cho, Hyun Deuk, Kim, Kyung-Ju, Kim, Sung Yong, Han, Sun Wook, Kim, Han Jo, Bae, Sang Byung, Lee, Hyun Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822107/ https://www.ncbi.nlm.nih.gov/pubmed/27066096 http://dx.doi.org/10.4048/jbc.2016.19.1.53 |
Ejemplares similares
-
Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer
por: Cho, Hyun Deuk, et al.
Publicado: (2015) -
Clinicopathological Significance of Elevated PIK3CA Expression in Gastric Cancer
por: Jang, Si-Hyong, et al.
Publicado: (2016) -
Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating
Lymphocytes Is Associated with Better Prognosis in Breast Cancer
por: Bae, Sang Byung, et al.
Publicado: (2016) -
Clinicopathologic and Prognostic Significance of Transducin-Like Enhancer of Split 1 Protein Expression in Invasive Breast Cancer
por: Lee, Ji-Hye, et al.
Publicado: (2017) -
Mediastinal Glomus Tumor: A Case Report and Literature Review
por: Jang, Si-Hyong, et al.
Publicado: (2015)